ARV-Based HIV Prevention Technologies: Developing the Capacity and Tools to Deliver New Prevention Products

THE ISSUE IN BRIEF

Supported by the Bill & Melinda Gates Foundation, this project examines the delivery and implementation of the use of antiretroviral drugs as a pre-exposure prophylaxis (PrEP) in comprehensive HIV prevention programs. The O’Neill Institute is part of a larger global effort with several partners, which include Imperial College London, the London School of Hygiene and Tropical Medicine, WHO, UNAIDS, Results for Development Institute, and AVAC.